Tech Company Financing Transactions

Tragara Pharmaceuticals Funding Round

Domain Associates, Mitsubishi Corporation and Morgenthaler Ventures joined a $40 million Series A funding round for Tragara Pharmaceuticals. The round was announced on 3/15/2007.

Transaction Overview

Company Information

Company Status

Private & Independent

Industry

Biopharmaceutical

Mailing Address

3152 Lionshead Ave.
Carlsbad, CA 92010
USA

Phone

(858) 350-6900

Website

www.tragarapharma.com

Email Address

[email protected]

Overview

Tragara Pharmaceuticals, Inc. is a pharmaceutical company based in San Diego, California focused on the clinical and commercial development of proprietary drugs for the treatment of cancer and inflammation-related diseases.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chief Executive Officer

Tracy Parrott

        

Chief Financial Officer

Dennis Bilski

        

VP - Bus. Development

Chris LeMasters

        

VP - Manufacturing

Stuart Gallant

        

Browse more venture capital transactions:

Prev: 3/15/2007: Capella Photonics venture capital transaction
Next: 3/15/2007: WhiteFence venture capital transaction

Share this article

Where The Data Comes From

We do our best to report on every notable VC transaction. VC investment data records on this site are derived from a variety of public sources. The data is sourced from VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary